741 related articles for article (PubMed ID: 18937970)
1. Prospective evaluation of prognostic significance of the tumor-free distance from uterine serosa in surgically staged endometrial adenocarcinoma.
Schwab KV; O'Malley DM; Fowler JM; Copeland LJ; Cohn DE
Gynecol Oncol; 2009 Jan; 112(1):146-9. PubMed ID: 18937970
[TBL] [Abstract][Full Text] [Related]
2. Tumour-free distance from serosa is a better prognostic indicator than depth of invasion and percentage myometrial invasion in endometrioid endometrial cancer.
Chattopadhyay S; Galaal KA; Patel A; Fisher A; Nayar A; Cross P; Naik R
BJOG; 2012 Sep; 119(10):1162-70. PubMed ID: 22804815
[TBL] [Abstract][Full Text] [Related]
3. Is there a prognostic difference between depth of myometrial invasion and the tumor-free distance from the uterine serosa in endometrial cancer?
Lindauer J; Fowler JM; Manolitsas TP; Copeland LJ; Eaton LA; Ramirez NC; Cohn DE
Gynecol Oncol; 2003 Dec; 91(3):547-51. PubMed ID: 14675674
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of tumor-free distance and depth of myometrial invasion as prognostic factors for lymph node metastases in endometrial cancer.
Kondalsamy-Chennakesavan S; van Vugt S; Sanday K; Nicklin J; Land R; Perrin L; Crandon A; Obermair A
Int J Gynecol Cancer; 2010 Oct; 20(7):1217-21. PubMed ID: 21495232
[TBL] [Abstract][Full Text] [Related]
5. Absolute depth of myometrial invasion in endometrial cancer is superior to the currently used cut-off value of 50%.
Geels YP; Pijnenborg JM; van den Berg-van Erp SH; Snijders MP; Bulten J; Massuger LF
Gynecol Oncol; 2013 May; 129(2):285-91. PubMed ID: 23422503
[TBL] [Abstract][Full Text] [Related]
6. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.
Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691
[TBL] [Abstract][Full Text] [Related]
7. Predictors of final histology in patients with endometrial cancer.
Frumovitz M; Singh DK; Meyer L; Smith DH; Wertheim I; Resnik E; Bodurka DC
Gynecol Oncol; 2004 Dec; 95(3):463-8. PubMed ID: 15581947
[TBL] [Abstract][Full Text] [Related]
8. The significance of the amount of myometrial invasion in patients with Stage IB endometrial carcinoma.
Alektiar KM; McKee A; Lin O; Venkatraman E; Zelefsky MJ; Mychalczak BR; McKee B; Hoskins WJ; Barakat RR
Cancer; 2002 Jul; 95(2):316-21. PubMed ID: 12124832
[TBL] [Abstract][Full Text] [Related]
9. Significance of lower uterine segment involvement in women with stage I endometrial adenocarcinoma.
Gemer O; Uriev L; Harkovsky T; Peled R; Ben-Dor D; Barak F; Segal S
J Reprod Med; 2004 Sep; 49(9):703-6. PubMed ID: 15493559
[TBL] [Abstract][Full Text] [Related]
10. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA
Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
[TBL] [Abstract][Full Text] [Related]
11. Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion.
Orezzoli JP; Sioletic S; Olawaiye A; Oliva E; del Carmen MG
Gynecol Oncol; 2009 Jun; 113(3):316-23. PubMed ID: 19345400
[TBL] [Abstract][Full Text] [Related]
12. The risk of lymph node metastasis based on myometrial invasion and tumor grade in endometrioid uterine cancers: a multicenter, retrospective Korean study.
Lee KB; Ki KD; Lee JM; Lee JK; Kim JW; Cho CH; Kim SM; Park SY; Jeong DH; Kim KT
Ann Surg Oncol; 2009 Oct; 16(10):2882-7. PubMed ID: 19484311
[TBL] [Abstract][Full Text] [Related]
13. [Multivariate analysis of prognostic factors in endometrial carcinoma].
Li B; Wu LY; Li SM; Zhang WH; Zhang R; Ma SK
Ai Zheng; 2004 Sep; 23(9):1085-8. PubMed ID: 15363208
[TBL] [Abstract][Full Text] [Related]
14. The prognostic significance of lower uterine segment involvement in surgically staged endometrial cancer patients with negative nodes.
Brown AK; Madom L; Moore R; Granai CO; DiSilvestro P
Gynecol Oncol; 2007 Apr; 105(1):55-8. PubMed ID: 17157904
[TBL] [Abstract][Full Text] [Related]
15. Lymph node metastasis in endometrioid adenocarcinomas of the uterine corpus with occult cervical involvement.
Boren T; Lea J; Kehoe S; Miller DS; Richardson D
Gynecol Oncol; 2012 Oct; 127(1):43-6. PubMed ID: 22713294
[TBL] [Abstract][Full Text] [Related]
16. Lymphovascular space invasion does not predict vaginal relapses in stage I endometrioid adenocarcinoma of the endometrium.
Desrosiers L; Fadare O; Xiao ZF; Dresser K; Wang SA
Ann Diagn Pathol; 2008 Apr; 12(2):112-7. PubMed ID: 18325471
[TBL] [Abstract][Full Text] [Related]
17. Frozen section analyses as predictors of lymphatic spread in patients with early-stage uterine cancer.
Frumovitz M; Slomovitz BM; Singh DK; Broaddus RR; Abrams J; Sun CC; Bevers M; Bodurka DC
J Am Coll Surg; 2004 Sep; 199(3):388-93. PubMed ID: 15325608
[TBL] [Abstract][Full Text] [Related]
18. Hysterectomy for uterine adenocarcinoma in the elderly: tumor characteristics, and long-term outcome.
Gayar OH; Robbins JR; Parikh K; Lu M; Buekers T; Munkarah A; Elshaikh MA
Gynecol Oncol; 2011 Oct; 123(1):71-5. PubMed ID: 21767871
[TBL] [Abstract][Full Text] [Related]
19. Reassessment of myometrial invasion in endometrial carcinoma.
Kaku T; Tsuruchi N; Tsukamoto N; Hirakawa T; Kamura T; Nakano H
Obstet Gynecol; 1994 Dec; 84(6):979-82. PubMed ID: 7970481
[TBL] [Abstract][Full Text] [Related]
20. Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer.
Amant F; Cadron I; Fuso L; Berteloot P; de Jonge E; Jacomen G; Van Robaeys J; Neven P; Moerman P; Vergote I
Gynecol Oncol; 2005 Aug; 98(2):274-80. PubMed ID: 15972232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]